Form 8-K - Current report:
SEC Accession No. 0001739614-21-000004
Filing Date
2021-01-13
Accepted
2021-01-13 09:03:57
Documents
2
Period of Report
2021-01-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fpr1132021.htm 8-K 19988
2 EX-99.1 exhibit991pressreleasefpr1.htm EX-99.1 13972
  Complete submission text file 0001739614-21-000004.txt   35062
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

EIN.: 824257312 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39452 | Film No.: 21525155
SIC: 2836 Biological Products, (No Diagnostic Substances)